Rockwell Automation launches PharmaSuite 12.00 for secure, scalable deployments.

Rockwell Automation has launched FactoryTalk PharmaSuite 12.00, a new Manufacturing Execution System (MES) designed to meet the unique needs of regulated manufacturing environments in the pharmaceutical and biopharmaceutical industries. The latest version aims to simplify system management, accelerate deployments, and enhance production scalability while ensuring compliance. The new MES will enable companies to act faster while maintaining compliance.

Rockwell Automation, Inc. (NYSE: ROK), a global leader in industrial automation and digital transformation, has announced the launch of FactoryTalk PharmaSuite 12.00. This new Manufacturing Execution System (MES) is designed to meet the unique needs of regulated manufacturing environments in the pharmaceutical and biopharmaceutical industries. The latest version aims to simplify system management, accelerate deployments, and enhance production scalability while ensuring compliance.

The new PharmaSuite 12.00 introduces a modular architecture and new cloud-ready capabilities, providing manufacturers with increased agility to meet rapidly evolving production demands. It also features enhanced cybersecurity to support the stringent compliance and data integrity standards required in regulated life sciences environments. The system's development uses certified secure development practices, aligning with industry standards like IEC 62443.

Key features of FactoryTalk PharmaSuite 12.00 include cloud-based deployment using Kubernetes and Linux containers, a new setup tool (MICKA) for automated installation, modular design for scalability, built-in monitoring tools, enhanced cybersecurity, and simplified upgrade processes. The system aims to help manufacturers scale operations faster, simplify global rollouts, and reduce validation time and costs while maintaining regulatory compliance.

The timing of this launch is strategic, as BioPhorum has identified that current MES solutions are widely perceived as expensive, implementation-heavy, and insufficiently flexible for modern operations. Rockwell Automation's PharmaSuite 12.00 directly addresses these pain points, providing a simplified, configurable, and future-ready platform for regulated life sciences production.

Martin Petrick, business manager, MES at Rockwell Automation, stated, "PharmaSuite 12.00 represents a major step forward in helping life sciences manufacturers embrace modular, digital production while maintaining the highest standards of performance, availability, compliance, and security. With the flexibility to deploy in the cloud, on-premises, or in hybrid models, manufacturers can scale operations faster, simplify global rollouts, and reduce the time and cost of validation."

FactoryTalk PharmaSuite 12.00 builds on more than 15 years of continuous development and industry expertise. It provides pharmaceutical and biopharmaceutical manufacturers with a modern, regulatory-compliant MES platform that supports scalable production, rapid deployment, and digital transformation goals.

References
[1] https://www.stocktitan.net/news/ROK/rockwell-automation-launches-pharma-suite-12-00-to-accelerate-secure-r42jj5eff8sm.html
[2] https://www.prnewswire.co.uk/news-releases/rockwell-automation-launches-pharmasuite-12-00-to-accelerate-secure-scalable-deployments-302453100.html
[3] https://www.prnewswire.com/news-releases/rockwell-automation-launches-pharmasuite-12-00-to-accelerate-secure-scalable-deployments-302453073.html